We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$171M
AUM Growth
-$4.07M
Cap. Flow
-$2.81M
Cap. Flow %
-1.64%
Top 10 Hldgs %
93.32%
Holding
41
New
Increased
4
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$2.25M
2
ALT icon
Altimmune
ALT
+$604K
3
MAG
MAG Silver
MAG
+$380K
4
SA
Seabridge Gold
SA
+$114K

Sector Composition

Rank Sector Weight
1 Healthcare 91.85%
2 Materials 3.11%
3 Financials 0.99%
4 Industrials 0.7%
5 Consumer Staples 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$136M 79.57%
900,844
ALDX icon
2
Aldeyra Therapeutics
ALDX
$91.7M
$10M 5.86%
1,877,305
+374,845
+25% +$2.25M
ENTX icon
3
Entera Bio
ENTX
$101M
$2.58M 1.51%
2,484,275
ALT icon
4
Altimmune
ALT
$539M
$2.22M 1.3%
173,864
+40,886
+31% +$604K
CVS icon
5
CVS Health
CVS
$137B
$1.38M 0.81%
14,500
BAH icon
6
Booz Allen Hamilton
BAH
$8.7B
$1.2M 0.7%
13,000
TMO icon
7
Thermo Fisher Scientific
TMO
$211B
$1.07M 0.62%
2,100
APLT
8
DELISTED
Applied Therapeutics
APLT
$1.01M 0.59%
1,082,123
MO icon
9
Altria Group
MO
$122B
$917K 0.54%
22,700
V icon
10
Visa
V
$677B
$862K 0.5%
4,850
BX icon
11
Blackstone
BX
$104B
$838K 0.49%
10,000
-6,000
-38% -$581K
CRBP icon
12
Corbus Pharmaceuticals
CRBP
$170M
$833K 0.49%
168,196
GLW icon
13
Corning
GLW
$126B
$773K 0.45%
26,600
AEM icon
14
Agnico Eagle Mines
AEM
$72.6B
$650K 0.38%
15,393
MAG
15
DELISTED
MAG Silver
MAG
$599K 0.35%
48,000
+30,700
+177% +$380K
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$586K 0.34%
19,532
-3,609
-16% -$887K
FNV icon
17
Franco-Nevada
FNV
$41.4B
$585K 0.34%
4,900
SILV
18
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$553K 0.32%
100,000
MMX
19
DELISTED
Maverix Metals Inc. Common Shares
MMX
$553K 0.32%
165,000
WPM icon
20
Wheaton Precious Metals
WPM
$50.6B
$534K 0.31%
16,500
OR icon
21
OR Royalties Inc
OR
$5.47B
$529K 0.31%
235,000
SA
22
Seabridge Gold
SA
$2.8B
$487K 0.28%
41,000
+9,000
+28% +$114K
PAAS icon
23
Pan American Silver
PAAS
$18.6B
$468K 0.27%
29,500
EQX icon
24
Equinox Gold
EQX
$7.32B
$361K 0.21%
99,000
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$349K 0.2%
5,000

Similar funds

Knoll Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Knoll Capital Management held 41 positions worth $171M, down 2.3% from $175M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Knoll Capital Management's Q3 2022 filing shows 4 increased, 4 reduced and 8 closed positions. The largest sale was Arista Networks, an estimated $1.29M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 87% a quarter earlier, followed by Materials and Financials.

  • Knoll Capital Management added most to Aldeyra Therapeutics in Q3 2022, an estimated $2.25M increase.
  • Knoll Capital Management's biggest Q3 2022 reduction was Eiger BioPharmaceuticals, Inc., cutting an estimated $887K.
  • Knoll Capital Management fully exited Arista Networks in Q3 2022, selling an estimated $1.29M.
  • Knoll Capital Management's ten largest holdings make up 93% of its $171M portfolio in Q3 2022.
  • Knoll Capital Management opened 0 new positions and closed 8 in Q3 2022.
  • Knoll Capital Management's portfolio value fell 2.3% quarter-over-quarter to $171M.

Based on Knoll Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.